From November 15 to 17, 2024, the first International Anti-Aging and Health Preservation Technology Conference was successfully held in Shenzhen. The conference, themed "The Era of Health Preservation and Technology Against Aging," deeply focused on the fields of anti-aging and health preservation, and discussed hot topics including aging detection and evaluation, and anti-aging through food and medicine.

 

This conference was a grand academic exchange event. MingCeler marketing department also took this opportunity to set up a booth at the venue, where they provided detailed information about model mice to the on-site customers, offered technical support, and discussed the future of the industry with colleagues.

 

Dr. Wu Guangming gave a thematic report titled "Rapid Preparation Technology for the Next Generation of Complex Gene Editing Animal Models," systematically introducing the development mechanism of mouse embryonic stem cells to the high-difficulty embryo operation technology - tetraploid complementation technology and the latest application progress.

 

The tetraploid complementation technology was invented more than 20 years ago, but its success rate has always been very low, and it can only be carried out in a few top laboratories at home and abroad. Apart from Dr. Wu Guangming's research team, the birth rate of reported mice has only been 1-5%, and it can only be used for laboratory scientific research.

 

Currently, the unique and efficient tetraploid complementation technology scheme of Dr. Wu Guangming's research team can significantly increase the birth rate of mice to 30-60%, solving the bottleneck of industrial application of tetraploid complementation technology. It can directly prepare gene-edited target mice from mouse embryonic stem cells, bypassing the time-consuming breeding and selection steps of conventional technology, and greatly shortening the modeling cycle.

 

The industrialization of this technology can provide high-speed, high-efficiency, and high-quality customized services for various genetically modified model mice to global universities, research institutions, hospitals, pharmaceutical companies, and other life and health-related research teams. It has a leading advantage in the modeling cycle globally and can greatly promote projects such as vaccine research and development, new drug research and development, precision medicine, and emergency health event scientific research in China. It also provides a rapid preparation possibility for the demand for complex animal models in disease research, and is expected to significantly promote the progress of related research in the field of life sciences.

 

At the conference, experts, scholars, and attendees had an enthusiastic interactive exchange with Dr. Wu on tetraploid complementation technology and its applications.

 

As a technology developer focusing on rapid and personalized customization services for various genetically modified model mice, Minxun Biology actively participated in this biopharmaceutical industry exchange and had a relaxed and pleasant professional exchange and joint discussion of industry needs with colleagues in the industry.

 

In this exhibition, Minxun Biology showcased Lamin A progeria mice, gene-edited mouse models, and technical services.

 

In response to customer inquiries and business-related discussions, our company's professionals actively answered customer questions and provided a detailed introduction to the company's business and the capabilities of services related to model mice, in line with customer's follow-up needs.